CDC: Vaccines Help Millions

A 20-year-long US immunization program will prevent more than 700,000 deaths and 300 million illnesses in coming years, according to new data from the US Centers for Disease Control and Prevention.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

CDC PUBLIC HEALTH IMAGE LIBRARYThe Vaccines for Children program (VFC), which provides vaccines to kids whose families cannot afford them, was launched in 1994 in response to a spike in deadly measles cases in the United States. Now, 20 years later, officials at the US Centers for Disease Control and Prevention (CDC) estimate that the program will save some 732,000 participants, as well as prevent more than 21 million hospitalizations and 322 million illnesses.

“Thanks to the VFC program, children in our country are no longer at significant risk from diseases that once killed thousands each year,” CDC Director Tom Frieden said in a statement.

The report comes at a time when measles is actually on the rise in the U.S., with 189 cases reported last year and another 129 on the books so far for 2014. At least 34 of this year’s cases appear to have been brought to the country by people that had been infected overseas. “Current outbreaks of measles in the U.S. serve as a reminder that these diseases are only a plane ride away,” Frieden said. “Borders can’t stop measles, but vaccination can.”

Unfortunately, persistent beliefs that vaccines are linked to autism or other ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Jef Akst

    Jef Akst was managing editor of The Scientist, where she started as an intern in 2009 after receiving a master’s degree from Indiana University in April 2009 studying the mating behavior of seahorses.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours

iStock

Agilent BioTek Cytation C10 Confocal Imaging Reader

agilent technologies logo